BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma

Toby A. Eyre, Nirav N. Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang, Chan Y. Cheah, Yuqin Song, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J. Andorsky, Hannah M. Messersmith, Amy S. Ruppert, Valerie A. Muthig, Rodrigo Ito, Michael L. Wang

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'BRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences